COVID-19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy

Abstract

Introduction. Bronchial asthma (BA) is one of the most common chronic lung diseases in children. At the beginning of the COVID-19 pandemic, BA, like other lung diseases, was considered a risk factor for the severe course of COVID-19.

Aim of the study - to analyze the main clinical manifestations of COVID-19 in children with BA.

Material and methods. During 2020, 500 children with BA from the pulmonary department of the Sechenov University Children’s hospital were questioned. 3 % of them (15 children) were with COVID-19. Moreover, clinical picture of COVID-19 was analyzed in other 75 children with BA and 53 children without BA, who were observed in outpatient department and in Moscow pulmonary sanatorium N 15.

Results. It has been shown that the symptoms of COVID-19 can be similar to those of an exacerbation of asthma and manifest itself as dry cough and shortness of breath, and fever, which can also be observed with exacerbations of asthma against the background of a respiratory infection of any genesis.

Conclusion. Based on the factual clinical material, it was shown that the new coronavirus infection is easier in children, and in asthmatics among patients with less pronounced clinical symptoms.

Keywords:children; bronchial asthma; new coronavirus infection; COVID-19; SARS-CoV-2 virus

For citation: Geppe N.A., Kolosova N.G., Shakhnazarova M.D., Malakhov A.B., Timofeev Yu.S., Samartseva V.G., Glazachev O.S., Grebeneva I.V., Romantseva E.V, Kalinovskaya I.I., Odinaeva N.D. COVID-19 in children with bronchial asthma: clinical manifestations, course options, approaches to therapy. Immunologiya. 2021; 42 (3): 254-60. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-254-260 (in Russian)

Funding. The study had no sponsor support.

Conflict of interests. The authors declare no conflict of interests.

References

1. Ministry of Health of the Russian Federation. Statistical information for 2017 [Electronic resource]. URL: https://minzdrav.gov.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-materi-aly/statisticheskiy-sbornik-2017-god (in Russian)

2. National program «Bronchial asthma in children. Treatment strategy and prevention». 5th ed. Moscow, 2017. (in Russian)

3. Galitskaya M.A., Kurbacheva O.M., Shilovsky I.P., Nikol’sky A.A., Nikonova A.A., Dyneva M.E., Khaitov M.R. Some features of inflammation in patients with atopic bronchial asthma when exposed to respiratory viruses. Immunologiya. 2020; 41 (2): 154-63. DOI: https://doi.org/10.33029/0206-4952-2020-41-2-154-163 (in Russian)

4. Timoshenko D.O., Kofiadi I.A., Gudima G.O., Kurbacheva O.M. Epigenetics of bronchial asthma. Immunologiya. 2021; 42 (2): 93-101. DOI: https://doi.org/10.33029/0206-4952-2021-42-2-93-101 (in Russian)

5. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020; 145 (6): e20200702. DOI: https://doi.org/10.1542/peds.2020-0702

6. Cui X., Zhao Z., Zhang T., et al. A systematic review and metaanalysis of children with coronavirus disease 2019 (COVID-19). J. Med. Virol. 2021; 93 (2): 1057-69. DOI: https://doi.org/10.1002/jmv.26398

7. Williams P.C.M., Howard-Jones A.R., Hsu P., Palasanthiran P., Gray P.E., McMullan B.J., Britton P.N., Bartlett A.W. SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings. Pathology. 2020; 52 (7): 801-8.

8. World Health Organization (WHO) Coronavirus Disease (COVID-19) Pandemic. URL: https://covid19.who.int

9. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular immunological aspects of diagnosis, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198-210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210 (in Russian)

10. Methodical recommendations «Features of clinical manifestations and treatment of the disease caused by a new coronavirus infection (COVID-19) in children». Version 2 (03.07.2020). URL: https:// static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf (in Russian)

11. Morais-Almeida M., Pite H., Aguiar R., Ansotegui I., Bous-quet J. Asthma and the coronavirus disease 2019 pandemic: a literature review. Int. Arch. Allergy Immunol. 2020; 181 (9): 680-8. DOI: https://doi.org/10.1159/000509057

12. Parri N., Lenge M., Buonsenso D.; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with COVID-19 in pediatric emergency departments in Italy. N. Engl. J. Med. 2020; 383 (2): 187-90. DOI: https://doi.org/10.1056/NEJMc2007617

13. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et al.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N. Engl. J. Med. 2020; 382 (17): 1663-5.

tor ACE2. J. Allergy Clin. Immunol. 2020; 146 (1): 203-6.e3. DOI: https://doi.org/10.1016/jjaci.2020.04.009

21. Хаитов Р.М., Пинегин Б.В., Пащенков М.В. Эпителиальные клетки дыхательных путей как равноправные участники врожденного иммунитета и потенциальные мишени для иммуно-тропных средств. Иммунология. 2020; 41 (2): 107-13. DOI: https:// doi.org/10.33029/0206-4952-2020-41-2-107-113

22. Ciprandi G., Licari A., Filippelli G., Tosca M.A., Marseg-lia G.L. Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2020; 125 (3): 361-2. DOI: https://doi.org/10.1016/j. anai.2020.06.001

23. Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K. et al. COVID-19 in critically ill patients in the Seattle region: case series. N. Engl. J. Med. 2020; 382 (21): 2012-22.

24. Global strategy for asthma management and prevention (GINA). Updated 2020. URL: www.ginasthma.com

25. Yamaya M., Nishimura H., Deng X. et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020; 58: 15568. DOI: https://doi.org/https://doi.org/10.1016/j.resinv.2019.12.005

26. Peters M.C., Sajuthi S., Deford P., Christenson S., Rios C.L., Montgomery M.T. et al. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am. J. Respir. Crit. Care Med. 2020; 202: 83-90.

14. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et a.; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N. Engl. J. Med. 2020; 382(17): 1663-5.

15. Papadopoulos N.G., Custovic A., Deschildre A., et al. Impact of COVID-19 on pediatric asthma: practice adjustments and disease burden. J. Allergy Clin. Immunol. Pract. 2020; 8: 2592-9. DOI: https://doi.org/10.1016/jjaip.2020.06.001

16. Papadopoulos N.G., Mathioudakis A.G., Custovic A., et al. Childhood asthma outcomes during the COVID-19 pandemic: findings from the PeARL multinational cohort. Allergy. 2021; Feb. 20. DOI: https://doi.org/10.1111/all.14787

17. Chavasse R.J. COVID-19: reduced asthma presentations in children BMJ. 2020; 370: m2806. DOI: https://doi.org/10.1136/bmj.m2806

18. Kaye L., Theye B., Smeenk I., Gondalia R., Barrett M.A., Stempel D.A. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J. Allergy Clin. Immunol. Pract. 2020; 8: 2385-6.

19. Krivec U., Kofol Seliger A., Tursic J. COVID-19 lockdown dropped the rate of paediatric asthma admissions. Arch. Dis. Child. 2020; 105: 809-10.

20. Jackson D.J., Busse W.W., Bacharier L.B., et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020; 146 (1): 203-6.e3. DOI: https://doi.org/10.1016/jjaci.2020.04.009

21. Khaitov R.M., Pinegin B.V., Pashchenkov M.V. Epithelial cells of the respiratory tract as equal participants in innate immunity and potential targets for immunotropic agents. Immunologiya. 2020; 41 (2): 107-13. DOI: https://doi.org/10.33029/0206-4952-2020-41-2-107-113 (in Russian)

22. Ciprandi G., Licari A., Filippelli G., Tosca M.A., Marseg-lia G.L. Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann. Allergy Asthma Immunol. 2020; 125 (3): 361-2. DOI: https://doi.org/10.1016/j. anai.2020.06.001

23. Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K., et al. COVID-19 in critically ill patients in the Seattle region: case series. N. Engl. J. Med. 2020; 382 (21): 2012-22.

24. Global strategy for asthma management and prevention (GINA). Updated 2020. URL: www.ginasthma.com

25. Yamaya M., Nishimura H., Deng X., et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir. Investig. 2020; 58: 15568. DOI: https://doi.org/https://doi.org/10.1016/j.resinv.2019.12.005

26. Peters M.C., Sajuthi S., Deford P., Christenson S., Rios C.L., Montgomery M.T., et al. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am. J. Respir. Crit. Care Med. 2020; 202: 83-90.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)


JOURNALS of «GEOTAR-Media»